Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab
Eur Respir J
.
2018 Aug 16;52(2):1801025.
doi: 10.1183/13993003.01025-2018.
Print 2018 Aug.
Authors
David J Allen
1
,
Leanne-Jo Holmes
1
,
Kerry A Hince
1
,
Rachael Daly
1
,
Calra Ustabashi
1
,
Gael Tavernier
1
Affiliation
1
Severe Asthma Service, Northwest Lung Centre, Wythenshawe Hospital, Manchester, UK.
PMID:
29976649
DOI:
10.1183/13993003.01025-2018
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Asthmatic Agents*
Asthma*
Biological Products*
Forced Expiratory Volume / drug effects
Humans
Omalizumab
Substances
Anti-Asthmatic Agents
Biological Products
Omalizumab